Gary E. Raskob - Concepedia

Author

Gary E. Raskob

University of Oklahoma Health Sciences Center ORCID

Also Known As

Alex Spyropoulos, Andreas Dietz, Beckman, Michele G., G E Raskob, G RASKOB, G Raskob, G. E. Raskob, G. Raskob, G.E. RASKOB, G.E. Raskob

257

Publications

28.5K

Citations

H-Index

114

Concepts

All Affiliations

University of Oklahoma Health Sciences Center McMaster University Thrombosis and Atherosclerosis Research Institute University of Calgary Amsterdam UMC Location University of Amsterdam

About

Gary E. Raskob is an author at University of Oklahoma Health Sciences Center specializing in medicine, thrombosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	57	9.2K
2	Public Health	20	25	3.9K
3	Health Sciences	6	6	571
4	Arts	3	3	124
5	Engineering	1	1	33

Gary E. Raskob

Publications

17.9K

Citations

H-Index

Page 1

	Year	Citations
Antithrombotic Therapy for Venous Thromboembolic Disease Clive Kearon, Susan R. Kahn, Giancarlo Agnelli, CHEST Journal ThrombosisVenous DiseaseVenous ThrombosisAntithrombotic TherapyHematology	2008	2K
Apixaban for Extended Treatment of Venous Thromboembolism Giancarlo Agnelli, Harry R. Büller, Alexander T. Cohen, New England Journal of Medicine	2012	1.3K
Pulmonary Arterial Hypertension David B. Badesch, Gary E. Raskob, C. Gregory Elliott, CHEST Journal HypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseasePulmonary Physiology	2009	1.2K
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial Michael R. Lassen, Gary E. Raskob, Alexander Gallus, The Lancet ThrombosisClinical TrialsKnee ReplacementOrthopaedicsApixaban Versus Enoxaparin	2010	775
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis R. Hull, J. Hirsh, Richard M. Jay, New England Journal of Medicine	1982	735
Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein Thrombosis Russell D. Hull, Gary E. Raskob, Jack Hirsh, New England Journal of Medicine	1986	728
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis Russell D. Hull, Gary E. Raskob, Graham F. Pineo, New England Journal of Medicine	1992	705
Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement Michael R. Lassen, Gary E. Raskob, Alexander Gallus, New England Journal of Medicine	2009	692
ADAMTS13 activity in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients Sara K. Vesely, James N. George, Bernhard Lämmle, Blood	2003	669
Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer Russell D. Hull, Graham F. Pineo, Rollin Brant, The American Journal of Medicine ThrombosisVenous ThrombosisCardiovascular DiseaseMedicineHematology	2006	603

Page 1